This document discusses Catalonia's growing innovation hub status in Europe. It notes that in 2018, 17 multinationals announced new innovation set-ups in Catalonia. It also summarizes that Barcelona is ranked 34th worldwide and 8th in Europe for science output. Furthermore, the document highlights that Catalonia is currently one of the leading scientific hubs in Europe based on metrics like ERC grants and publications in Nature and Science.
Biocat is the institution that brings together the life sciences and healthcare innovation community in Catalonia.
Created in 2006 at the behest of the Government of Catalonia, Biocat’s mission is to maximize the economic and social impact of the life sciences and healthcare innovation of the BioRegion.
Biocat focuses its strategy on different key points:
- Raising awareness and promoting the ecosystem, creating tools and strategies for improving the knowledge of the Catalan healthcare sector and increasing its projection both at home and abroad, with the aim of positioning the BioRegion as an international reference.
- Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector.
- Accelerating technology transfer and business growth by supporting and carrying out activities for increasing the value of the sector, placing special emphasis on the added value of research, knowledge and technology transfer, internationalization and access to capital.
Keynote conference during the Biocat Report 2017, by Dr. Daria Tataj, Founder of a strategy firm Tataj Innovation, and Chairwoman of the RISE High-Level Advisors to Carlos Moedas, European Commissioner for Research, Science and Innovation
Biocat is the institution that brings together the life sciences and healthcare innovation community in Catalonia.
Created in 2006 at the behest of the Government of Catalonia, Biocat’s mission is to maximize the economic and social impact of the life sciences and healthcare innovation of the BioRegion.
Biocat focuses its strategy on different key points:
- Raising awareness and promoting the ecosystem, creating tools and strategies for improving the knowledge of the Catalan healthcare sector and increasing its projection both at home and abroad, with the aim of positioning the BioRegion as an international reference.
- Providing innovative training and developing talent, by designing and executing programs and initiatives to improve talent and entrepreneurship considered essential factors for the growth of the sector.
- Accelerating technology transfer and business growth by supporting and carrying out activities for increasing the value of the sector, placing special emphasis on the added value of research, knowledge and technology transfer, internationalization and access to capital.
Keynote conference during the Biocat Report 2017, by Dr. Daria Tataj, Founder of a strategy firm Tataj Innovation, and Chairwoman of the RISE High-Level Advisors to Carlos Moedas, European Commissioner for Research, Science and Innovation
The Law Factory: a git and dataviz approach to parliamentary bill-trackingmysociety
This was presented by Benjamin Ooghe-Tabanou from Médialab Sciences Po at the Impacts of Civic Technology Conference (TICTeC2016) in Barcelona on 28th April. You can find out more information about the conference here: https://www.mysociety.org/research/tictec-2016/
HealthTech is at the forefront of startups and scaleups, in the United States as well as in Europe. There is no single European healthcare system or market. Instead, high complexity and cultural diversity of healthcare systems makes it challenging to jump into multiple markets and thus to scaleup new companies. But if you take a close look, you’ll quickly notice that there is interesting stuff happening in Europe
With this report we want to provide a comprehensive review of investment in startups and high-growth HealthTech technology companies across 31 countries in Europe. Our aim is to provide data-driven guidance, insights, perspective and inspiration to stakeholders in the European scaleup ecosystem.
Presentation on the innovation ecosystem in Barcelona based on two articles. The presentation was held on April 26th during a TEDxMediterranean. the articles can be found here:
- http://www.barcinno.com/innovationinbarcelona/
- http://www.barcinno.com/barcelona-innovation-global-entrepreneur-leader/
Panel Session - BEYOND DISCIPLINES: THE TRANSFORMATION OF FASHION
Jonathan Chippindale (Holition), Jennifer Davies (Nabil Nayal), Prof Jane Harris (London College of Fashion), Lynda Petherick (Accenture UK) - Chair, Caroline Rush (British Fashion Council), Prof Stephen Russell (Uni of Leeds)
Like other areas of the creative industries the entire fashion ecosystem is in flux with multiple points of destabilisation. Rather than fear or deny this disruption the UK Fashion industry seems poised to embrace it. But to do so it needs to answer a range of challenges which spread across multiple research disciplines. We explore the nature of these challenges and how they are being met in a fast-moving global sub-sector of the creative industries.
Beyond is the research and development (R&D) conference for the creative industries. Featuring leading thinkers and practitioners, Beyond explores the dynamic relationship between research, academia and business innovation, bringing together business leaders, creatives, researchers, policy makers, journalists, funders and anyone with an interest in the future.
The Beyond conference took place on Tuesday 13th November 2018 at the Barbican in London. The programme featured speaker sessions, panel discussions and thought-provoking presentations, along with a video video presentation to showcase the recently launched Creative Industries Cluster Programme and the National Centre for Immersive Storytelling.
WEAR Sustain Symposium Launch Event London May 3rd, 2017 Camille Baker, PhD
These presentations discuss the WEAR Sustain EU funded project, it's core mandate & mission, as well as the application themes, rules and proposal writing process.
Startup Cities: Hangzhou, China - Me Convention 2018Chinwag
Wilson Tseng, Partnerships and Business Development Europe fpr Alibaba Cloud presented Hangzhou as part of the Startup Cities programme at the Me Convention 2018 in Stockholm featuring 20 cities, hosted by Sam Michel.
More at: https://toodlepip.co.uk/2018/20-startup-cities/
This catalogue contains information on over 50 Catalan
companies that are attending this Congress. They clearly
demonstrate the capacities of the Catalan business fabric
involved in ICTs and smart cities, promoting Catalonia as a
technological, business and investment hub in the Smart City
sector, especially with regard to mobility, lightning and waste.
Biocat has experience in accelerating healthcare projects and developing talent since 2008. In 10 years, Biocat has invested over €11 million, distributed in 300 programs attended by more than 2,300 students. By leveraging its expert, industry experienced, staff and extended network, Biocat has successfully accelerated 96 life sciences projects that generated 300 new job positions, increased the rate of successful commercialization and reduced the time to next phase. In 2013, in order to increase the impact of these strategic activities. Biocat launched Moebio, a new initiative that brings together diferent training programs to accelerate entrepreneurship and innovation in healthcare, that counts with the support of EIT Health. Moebio is ranked as one of the top accelerators in Europe according to rankings by Digitalhealth.careers, Mobile World Capital, Tech EU and HealthStartup.
Design Health Barcelona (d·HEALTH Barcelona) is a 9-month postgraduate program to develop entrepreneurs and future leaders in healthcare innovation. The course, based on the prestigious Stanford University's Biodesign Fellowship, has a needs-driven innovation focus and it guides multidisciplinary groups of students through a full cycle of innovation, from needs identification to designing and prototyping a viable solution, as well as searching for funding.
www.moebio.org
More Related Content
Similar to 2019 BioRegion of Catalonia Presentation
The Law Factory: a git and dataviz approach to parliamentary bill-trackingmysociety
This was presented by Benjamin Ooghe-Tabanou from Médialab Sciences Po at the Impacts of Civic Technology Conference (TICTeC2016) in Barcelona on 28th April. You can find out more information about the conference here: https://www.mysociety.org/research/tictec-2016/
HealthTech is at the forefront of startups and scaleups, in the United States as well as in Europe. There is no single European healthcare system or market. Instead, high complexity and cultural diversity of healthcare systems makes it challenging to jump into multiple markets and thus to scaleup new companies. But if you take a close look, you’ll quickly notice that there is interesting stuff happening in Europe
With this report we want to provide a comprehensive review of investment in startups and high-growth HealthTech technology companies across 31 countries in Europe. Our aim is to provide data-driven guidance, insights, perspective and inspiration to stakeholders in the European scaleup ecosystem.
Presentation on the innovation ecosystem in Barcelona based on two articles. The presentation was held on April 26th during a TEDxMediterranean. the articles can be found here:
- http://www.barcinno.com/innovationinbarcelona/
- http://www.barcinno.com/barcelona-innovation-global-entrepreneur-leader/
Panel Session - BEYOND DISCIPLINES: THE TRANSFORMATION OF FASHION
Jonathan Chippindale (Holition), Jennifer Davies (Nabil Nayal), Prof Jane Harris (London College of Fashion), Lynda Petherick (Accenture UK) - Chair, Caroline Rush (British Fashion Council), Prof Stephen Russell (Uni of Leeds)
Like other areas of the creative industries the entire fashion ecosystem is in flux with multiple points of destabilisation. Rather than fear or deny this disruption the UK Fashion industry seems poised to embrace it. But to do so it needs to answer a range of challenges which spread across multiple research disciplines. We explore the nature of these challenges and how they are being met in a fast-moving global sub-sector of the creative industries.
Beyond is the research and development (R&D) conference for the creative industries. Featuring leading thinkers and practitioners, Beyond explores the dynamic relationship between research, academia and business innovation, bringing together business leaders, creatives, researchers, policy makers, journalists, funders and anyone with an interest in the future.
The Beyond conference took place on Tuesday 13th November 2018 at the Barbican in London. The programme featured speaker sessions, panel discussions and thought-provoking presentations, along with a video video presentation to showcase the recently launched Creative Industries Cluster Programme and the National Centre for Immersive Storytelling.
WEAR Sustain Symposium Launch Event London May 3rd, 2017 Camille Baker, PhD
These presentations discuss the WEAR Sustain EU funded project, it's core mandate & mission, as well as the application themes, rules and proposal writing process.
Startup Cities: Hangzhou, China - Me Convention 2018Chinwag
Wilson Tseng, Partnerships and Business Development Europe fpr Alibaba Cloud presented Hangzhou as part of the Startup Cities programme at the Me Convention 2018 in Stockholm featuring 20 cities, hosted by Sam Michel.
More at: https://toodlepip.co.uk/2018/20-startup-cities/
This catalogue contains information on over 50 Catalan
companies that are attending this Congress. They clearly
demonstrate the capacities of the Catalan business fabric
involved in ICTs and smart cities, promoting Catalonia as a
technological, business and investment hub in the Smart City
sector, especially with regard to mobility, lightning and waste.
Biocat has experience in accelerating healthcare projects and developing talent since 2008. In 10 years, Biocat has invested over €11 million, distributed in 300 programs attended by more than 2,300 students. By leveraging its expert, industry experienced, staff and extended network, Biocat has successfully accelerated 96 life sciences projects that generated 300 new job positions, increased the rate of successful commercialization and reduced the time to next phase. In 2013, in order to increase the impact of these strategic activities. Biocat launched Moebio, a new initiative that brings together diferent training programs to accelerate entrepreneurship and innovation in healthcare, that counts with the support of EIT Health. Moebio is ranked as one of the top accelerators in Europe according to rankings by Digitalhealth.careers, Mobile World Capital, Tech EU and HealthStartup.
Design Health Barcelona (d·HEALTH Barcelona) is a 9-month postgraduate program to develop entrepreneurs and future leaders in healthcare innovation. The course, based on the prestigious Stanford University's Biodesign Fellowship, has a needs-driven innovation focus and it guides multidisciplinary groups of students through a full cycle of innovation, from needs identification to designing and prototyping a viable solution, as well as searching for funding.
www.moebio.org
Panel discussion: Being a successful healthcare entrepreneur: lessons from Boston to Barcelona, with numerous experts from CIMIT, Boston, in economics, development and strategic planning of medical devices; in prototypes and patents and founders of several startups.
Presentation of CRAASH Barcelona, the new project of Biocat (Moebio Barcelona). The initiative is a 12-week program that helps European research teams launch successful device, diagnostic and e-/digital health innovations to improve health and patient care.
Toby Reid, Managing Director at BioCity Scotland, was the keynote speaker of the Graduation Cerimony of d·HEALTH Barcelona 2017.
BioCity is UK's largest bioscience incubation centre. Over 200 companies are based in a BioCity Group business incubator, with a 91% survival rate of companies.
Moebio is he talent development initiative of Biocat to accelerate healthcare entrepreneurship.
Design Health Barcelona (d·HEALTH Barcelona) Is the full-time program of MOEBIO, inspired and modeled in the prestigiousStanford University's Biodesign Fellowshipthat seeks to train a team of fellows in the process of biodesign to develop innovative solutions.
Presentation of Mehrdad Hariri (Canadian Science Policy Centre (CPSC), CEO & President) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Zayna Khayat (MaRS Discovery District, Health System Innovation; MaRS EXCITE) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Susan Bannister (Massachusetts Life Sciences Center, Former President and CEO) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Vishal Gulati (Draper Esprit, Venture Partner; Horizon Discovery Group PLC, Board Director) at the Forum of the BioRegion of Catalonia, organized by Biocat.
Presentation of Simon Howell (Founding Non-Executive Director of MedCity and Guy’s Campus Dean at King’s College London King’s College London) at the Forum of the BioRegion of Catalonia, organized by Biocat.
The Health & Bio Team Dating project was created through the collaboration of four institutions: Banc Sabadell, the fifth-largest Spanish banking group, Biocat, Bosch i Gimpera Foundation and CataloniaBio, three bodies representing the life sciences sector in Catalonia.
The initiative aims to dynamize and promote the development of the Catalan bioentrepreneurial ecosystem by linking entrepreneurs with projects.
We expect this event to lead to formal collaborations between business professionals and research groups in balanced management teams to create new life sciences start-ups with high potential.
The BioRegion of Catalonia, a research and innovation hub in Southern Europe, participated at BIO 2015 in Philadelphia. Check the profile of delegation.
Presentation given by Iñaki Largo from the Technology Transfer Office of the University of the Basque Country in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
Presentation given by Fernando Javier Conesa from Polytechnic University of Valencia in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
Presentation given by Jean-Pierre Saintouil from Toulouse Tech Transfer in the framework of the Emergence Forum Barcelona
Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
4. #InformeBiocat#InformeBiocatbiocat.cat
BARCELONA IS #34 IN SCIENCE OUTPUT WORLDWIDE (AND #8
IN EUROPE)
Source: Nature Index 2018 S cience Cities; Fig ures in the g raph represent the fractional count (FC), which takes into account the share of authorship on each article
152
219
231
238
239
270
291
322
334
412
467
481
546
560
672
938
1676
1808
1980
2142
Leuven (86)
Heidelberg (52)
Vienna (48)
Stockholm (46)
Copenhagen (45)
Lausanne (37)
Barcelona (34)
Toronto (32)
Melbourne (31)
Oxford (23)
Munic (22)
Berlin (20)
Zurich (18)
Cambridge (17)
London (14)
Paris (8)
San Francisco (4)
Boston (3)
New York (2)
Beijing (1)
5. #InformeBiocatbiocat.cat
S W E D E N
382
333
252 248
190
140
101
0
200
400
600
SWE DEN AUS BEL CAT FIN IR
CATALONIA IS CURRENTLY ONE OF THE LEADING SCIENTIFIC
HUBS IN EUROPE
Sources: AG AU R (2007-March 2018);Web of Science (2013-2017)
CATALONIA
IRELAND
AUSTRIA
DENMARK
FINLAND
BELGIUM
304 290 280
208
181 156
89
0
100
200
300
400
SWE BEL CAT AUS DEN FIN IR
ERC
Grants
Nature + Science
6. Source: Biocat
FINANCE RAISED IS ON UPWARD TREND, ESPECIALLY
REGARDING PRIVATE INVESTMENT (investment in startups, in €M)
biocat.cat
Investment that
creates value
7. #InformeBiocatbiocat.cat
INTERNATIONAL INVESTORS ARE INCREASING
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
10 1 1 1
5
6
14
22
37
50
50
International
investors
Source:Biocat
(x10 in just 5 years)
United States
Netherlands
Belgium
France
Switzerland
Austria
Germany
Japan
Russia
United Kingdom
Norway
Mexico
Luxembourg
Italy
Israel
Ireland
Canada
China
11. #InformeBiocatbiocat.cat
LIFE SCIENCES VENTURE FINANCING (€M) BY COUNTRY
(2000-2017)
Source: Crunchbase and Biocat
FINLAND CATALONIA AUSTRIA DENMARK BELGIUM SWEDEN IRELAND
1,778.8
1,034.5
289.2
1,491.3
1,125.5
592.8
483.5